Results from a meta-analysis suggest patients with resectable dMMR/MSI-H gastric cancer can forgo perioperative chemotherapy.

Cabozantinib significantly improved progression free survival in patients with pNET and epNET compared with placebo.

Barriers contributing to underreporting of fatigue also include belief that symptom is sign disease is progressing and attempt to be a “good patient.” ...

After 3.5 years of follow-up, there was a 98% rate of minimal residual disease, and 9 patients were still in complete remission.

R1vascular (R1vasc) resection surgery leads to similar survival outcomes as R0 resection (median: 54 months vs 65 months) in patients with challenging mass-forming cholangiocarcinoma (MF-CCA), an ...

This is the first trial to prospectively demonstrate the impact of bone-protecting agents use on fracture risk for men receiving an androgen receptor pathway inhibitor.

HealthDay News — Some commonly prescribed photosensitizing drugs increase skin cancer risk, according to a study published online March 18 in Photodermatology, Photoimmunology & Photomedicine.